West Pharmaceutical Services (WST): Sr. VP & Chief HR Officer exercised options on 2,817 units
Annette F Favorite, Sr. VP & Chief HR Officer at West Pharmaceutical Services, reported an option exercise of 2,817 units.
- 2,817
- Derivative units
- Traded
- Apr 27, 2026
- Filed
- Apr 29, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Today, March 9, 2026 , West Pharmaceutical Services, Inc. (the “Company”) announced that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been hired in order to ensure a smooth transition.”
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 23, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Apr 27, 2026Insider · 2 peopleInsiders: 2 sales (~$1.1M)
What came next
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.7%
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 7, 2026Company filing · Form 8-K · Cyber incident, Reg FDReported a cybersecurity incident, and shared information with investors“On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.”
- May 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in the Original Report, the Company determined on May 7, 2026 that the Company had experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.”
- May 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on Form 8-K announcing that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board”) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been hired in order to ensure a smooth transition.”
- Jul 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Jul 23, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.0%
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for West Pharmaceutical Services
For West Pharmaceutical Services, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WST page.
Other recent filings by Annette F Favorite, Sr. VP & Chief HR Officer
- SEC Form 4 at West Pharmaceutical Services (WST)Sep 15, 2026
- SEC Form 4 at West Pharmaceutical Services (WST)Sep 15, 2026
- SEC Form 4 at West Pharmaceutical Services (WST)Sep 15, 2026
- SEC Form 4 at West Pharmaceutical Services (WST)Sep 10, 2026
- SEC Form 4 at West Pharmaceutical Services (WST)Sep 10, 2026
The full history of Annette F Favorite, Sr. VP & Chief HR Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which West Pharmaceutical Services (WST) insider traded, and how much?
Annette F Favorite, Sr. VP & Chief HR Officer at West Pharmaceutical Services, reported an option exercise of 2,817 units. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Apr 27, 2026. Filed: Apr 29, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about West Pharmaceutical Services recently?
For West Pharmaceutical Services, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the WST page.
Does this mean WST stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at West Pharmaceutical Services
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 10, 2026
- SEC Form 4Sep 10, 2026
Everything OQRO holds on this company is on its WST page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
